Medtronic PLC expects the launch of its next-generation MiniMed 780G hybrid closed-loop system will mark the start of the turnaround for its diabetes business.
During the virtual American Diabetes Association conference on 11 June, Medtronic announced the CE mark for its MiniMed 780G, indicating it for the treatment of type 1 diabetes in people...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?